Prestige Biologics Co., Ltd. engages in research, development, and supplying of pharmaceutical products. The company services include contract development, engineering, and manufacturing organization. It specializes in the development and production of both novel biologic agents and biosimilars. The company was founded on June 2, 2015 and is headquartered in Cheongju-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company